|
"dean andrew"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 國立成功大學 |
2016-02-06 |
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
|
Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyoergy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayle;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean F.;Hubner, Richard A.;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi;Moyo, Victor;Belanger, Bruce;Dhindsa, Navreet;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong |
| 國立成功大學 |
2016-02-01 |
Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy.
|
Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyorgy;Dean, Andrew;Shan, Yang-Shen;Jameson, Gayle S.;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean-Frederic;Hubner, Richard;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi S.;Moyo, Victor M.;Belanger, Bruce;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong |
| 國立成功大學 |
2016 |
Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
|
Siveke, Jens T.;Chen, Li-Tzong;Von Hoff, Daniel D;Li, Chung-Pin;Wang-Gillam, Andrew;Bodoky, Gyorgy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayel S;Macarulla, T.;Lee, K-H;Cunningham, D.;Blanc, J-F;Hubner, R. A.;Chiu, C-F;Schwartsmann, G.;Braiteh, F.;Moyo, V.;Belanger, B.;Bayever, E. |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
